nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—hypertension—metabolic syndrome X	0.945	1	CtDrD
Betaxolol—Emotional distress—Metformin—metabolic syndrome X	0.00322	0.0609	CcSEcCtD
Betaxolol—Acidosis—Metformin—metabolic syndrome X	0.00247	0.0468	CcSEcCtD
Betaxolol—Respiratory distress—Metformin—metabolic syndrome X	0.00215	0.0408	CcSEcCtD
Betaxolol—Rhinorrhoea—Metformin—metabolic syndrome X	0.00169	0.032	CcSEcCtD
Betaxolol—Rigors—Metformin—metabolic syndrome X	0.00168	0.0317	CcSEcCtD
Betaxolol—Accidental injury—Metformin—metabolic syndrome X	0.00155	0.0293	CcSEcCtD
Betaxolol—Neuropathy—Metformin—metabolic syndrome X	0.00128	0.0243	CcSEcCtD
Betaxolol—Ear pain—Metformin—metabolic syndrome X	0.00116	0.022	CcSEcCtD
Betaxolol—Injury—Metformin—metabolic syndrome X	0.00108	0.0204	CcSEcCtD
Betaxolol—Renal impairment—Metformin—metabolic syndrome X	0.00104	0.0197	CcSEcCtD
Betaxolol—Hypoglycaemia—Metformin—metabolic syndrome X	0.00102	0.0193	CcSEcCtD
Betaxolol—Lethargy—Metformin—metabolic syndrome X	0.00101	0.0192	CcSEcCtD
Betaxolol—Breast disorder—Metformin—metabolic syndrome X	0.000898	0.017	CcSEcCtD
Betaxolol—Cramp muscle—Metformin—metabolic syndrome X	0.000894	0.0169	CcSEcCtD
Betaxolol—Nasopharyngitis—Metformin—metabolic syndrome X	0.000888	0.0168	CcSEcCtD
Betaxolol—Influenza—Metformin—metabolic syndrome X	0.000858	0.0162	CcSEcCtD
Betaxolol—Angina pectoris—Metformin—metabolic syndrome X	0.000836	0.0158	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000798	0.0151	CcSEcCtD
Betaxolol—Infestation NOS—Metformin—metabolic syndrome X	0.000765	0.0145	CcSEcCtD
Betaxolol—Infestation—Metformin—metabolic syndrome X	0.000765	0.0145	CcSEcCtD
Betaxolol—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00075	0.0142	CcSEcCtD
Betaxolol—Bradycardia—Metformin—metabolic syndrome X	0.000699	0.0132	CcSEcCtD
Betaxolol—Rhinitis—Metformin—metabolic syndrome X	0.000689	0.013	CcSEcCtD
Betaxolol—Hypoaesthesia—Metformin—metabolic syndrome X	0.000684	0.0129	CcSEcCtD
Betaxolol—Eye disorder—Metformin—metabolic syndrome X	0.000642	0.0122	CcSEcCtD
Betaxolol—Flushing—Metformin—metabolic syndrome X	0.000638	0.0121	CcSEcCtD
Betaxolol—Cardiac disorder—Metformin—metabolic syndrome X	0.000638	0.0121	CcSEcCtD
Betaxolol—Angiopathy—Metformin—metabolic syndrome X	0.000623	0.0118	CcSEcCtD
Betaxolol—Immune system disorder—Metformin—metabolic syndrome X	0.000621	0.0117	CcSEcCtD
Betaxolol—Mediastinal disorder—Metformin—metabolic syndrome X	0.000619	0.0117	CcSEcCtD
Betaxolol—Chills—Metformin—metabolic syndrome X	0.000617	0.0117	CcSEcCtD
Betaxolol—Erythema—Metformin—metabolic syndrome X	0.000598	0.0113	CcSEcCtD
Betaxolol—Malnutrition—Metformin—metabolic syndrome X	0.000598	0.0113	CcSEcCtD
Betaxolol—Dysgeusia—Metformin—metabolic syndrome X	0.000586	0.0111	CcSEcCtD
Betaxolol—Muscle spasms—Metformin—metabolic syndrome X	0.000575	0.0109	CcSEcCtD
Betaxolol—Vision blurred—Metformin—metabolic syndrome X	0.000564	0.0107	CcSEcCtD
Betaxolol—Tremor—Metformin—metabolic syndrome X	0.00056	0.0106	CcSEcCtD
Betaxolol—Ill-defined disorder—Metformin—metabolic syndrome X	0.000555	0.0105	CcSEcCtD
Betaxolol—Malaise—Metformin—metabolic syndrome X	0.000539	0.0102	CcSEcCtD
Betaxolol—Syncope—Metformin—metabolic syndrome X	0.000536	0.0101	CcSEcCtD
Betaxolol—Palpitations—Metformin—metabolic syndrome X	0.000529	0.01	CcSEcCtD
Betaxolol—Loss of consciousness—Metformin—metabolic syndrome X	0.000526	0.00995	CcSEcCtD
Betaxolol—Chest pain—Metformin—metabolic syndrome X	0.000509	0.00964	CcSEcCtD
Betaxolol—Myalgia—Metformin—metabolic syndrome X	0.000509	0.00964	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000506	0.00957	CcSEcCtD
Betaxolol—Discomfort—Metformin—metabolic syndrome X	0.000503	0.00952	CcSEcCtD
Betaxolol—Oedema—Metformin—metabolic syndrome X	0.000488	0.00924	CcSEcCtD
Betaxolol—Infection—Metformin—metabolic syndrome X	0.000485	0.00918	CcSEcCtD
Betaxolol—Shock—Metformin—metabolic syndrome X	0.00048	0.00909	CcSEcCtD
Betaxolol—Nervous system disorder—Metformin—metabolic syndrome X	0.000479	0.00906	CcSEcCtD
Betaxolol—Thrombocytopenia—Metformin—metabolic syndrome X	0.000478	0.00904	CcSEcCtD
Betaxolol—Skin disorder—Metformin—metabolic syndrome X	0.000474	0.00897	CcSEcCtD
Betaxolol—Hyperhidrosis—Metformin—metabolic syndrome X	0.000472	0.00893	CcSEcCtD
Betaxolol—Anorexia—Metformin—metabolic syndrome X	0.000465	0.0088	CcSEcCtD
Betaxolol—Hypotension—Metformin—metabolic syndrome X	0.000456	0.00863	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000445	0.00842	CcSEcCtD
Betaxolol—Paraesthesia—Metformin—metabolic syndrome X	0.000438	0.00829	CcSEcCtD
Betaxolol—Dyspnoea—Metformin—metabolic syndrome X	0.000435	0.00824	CcSEcCtD
Betaxolol—Dyspepsia—Metformin—metabolic syndrome X	0.00043	0.00813	CcSEcCtD
Betaxolol—Decreased appetite—Metformin—metabolic syndrome X	0.000424	0.00803	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000421	0.00797	CcSEcCtD
Betaxolol—Fatigue—Metformin—metabolic syndrome X	0.000421	0.00796	CcSEcCtD
Betaxolol—Constipation—Metformin—metabolic syndrome X	0.000417	0.0079	CcSEcCtD
Betaxolol—Feeling abnormal—Metformin—metabolic syndrome X	0.000402	0.00761	CcSEcCtD
Betaxolol—Urticaria—Metformin—metabolic syndrome X	0.000388	0.00734	CcSEcCtD
Betaxolol—Asthenia—Metformin—metabolic syndrome X	0.00035	0.00663	CcSEcCtD
Betaxolol—Pruritus—Metformin—metabolic syndrome X	0.000345	0.00654	CcSEcCtD
Betaxolol—Diarrhoea—Metformin—metabolic syndrome X	0.000334	0.00632	CcSEcCtD
Betaxolol—Dizziness—Metformin—metabolic syndrome X	0.000323	0.00611	CcSEcCtD
Betaxolol—Vomiting—Metformin—metabolic syndrome X	0.00031	0.00587	CcSEcCtD
Betaxolol—Rash—Metformin—metabolic syndrome X	0.000308	0.00582	CcSEcCtD
Betaxolol—Dermatitis—Metformin—metabolic syndrome X	0.000308	0.00582	CcSEcCtD
Betaxolol—Headache—Metformin—metabolic syndrome X	0.000306	0.00579	CcSEcCtD
Betaxolol—Nausea—Metformin—metabolic syndrome X	0.00029	0.00549	CcSEcCtD
Betaxolol—CYP2D6—Metapathway biotransformation—FMO3—metabolic syndrome X	2.03e-05	0.00946	CbGpPWpGaD
Betaxolol—CYP2D6—Melatonin metabolism and effects—APOE—metabolic syndrome X	2e-05	0.0093	CbGpPWpGaD
Betaxolol—CYP2D6—Metapathway biotransformation—EPHX2—metabolic syndrome X	1.81e-05	0.00843	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—FMO3—metabolic syndrome X	1.75e-05	0.00813	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—FMO3—metabolic syndrome X	1.72e-05	0.00802	CbGpPWpGaD
Betaxolol—CYP1A2—Melatonin metabolism and effects—APOE—metabolic syndrome X	1.69e-05	0.00788	CbGpPWpGaD
Betaxolol—CYP1A2—Arachidonic acid metabolism—GGT1—metabolic syndrome X	1.61e-05	0.0075	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	1.6e-05	0.00744	CbGpPWpGaD
Betaxolol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	1.57e-05	0.00731	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	1.56e-05	0.00728	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—EPHX2—metabolic syndrome X	1.53e-05	0.00714	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor—LPL—metabolic syndrome X	1.4e-05	0.0065	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	1.37e-05	0.00637	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	1.34e-05	0.00623	CbGpPWpGaD
Betaxolol—CYP1A2—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	1.33e-05	0.00619	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor—CD36—metabolic syndrome X	1.33e-05	0.00618	CbGpPWpGaD
Betaxolol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	1.3e-05	0.00604	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	1.24e-05	0.00579	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	1.22e-05	0.00567	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	1.12e-05	0.0052	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	1.09e-05	0.00509	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	1.07e-05	0.00496	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	1.04e-05	0.00486	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—MTNR1B—metabolic syndrome X	1.04e-05	0.00485	CbGpPWpGaD
Betaxolol—CYP1A2—Phase II conjugation—GGT1—metabolic syndrome X	1.03e-05	0.00477	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—MTNR1B—metabolic syndrome X	1.02e-05	0.00475	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	1.01e-05	0.00471	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	9.89e-06	0.0046	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	9.57e-06	0.00446	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	9.36e-06	0.00436	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—HTR2C—metabolic syndrome X	8.12e-06	0.00378	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—metabolic syndrome X	8.02e-06	0.00373	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—HTR2C—metabolic syndrome X	7.94e-06	0.0037	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—GHRL—metabolic syndrome X	7.7e-06	0.00358	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—GHRL—metabolic syndrome X	7.53e-06	0.00351	CbGpPWpGaD
Betaxolol—CYP1A2—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	7.5e-06	0.00349	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	7.42e-06	0.00345	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—CNR1—metabolic syndrome X	7.29e-06	0.00339	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	7.26e-06	0.00338	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—CNR1—metabolic syndrome X	7.13e-06	0.00332	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—GGT1—metabolic syndrome X	7.08e-06	0.0033	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	6.21e-06	0.00289	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	6.07e-06	0.00283	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—GGT1—metabolic syndrome X	6e-06	0.00279	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	5.97e-06	0.00278	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—MTNR1B—metabolic syndrome X	5.89e-06	0.00274	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—metabolic syndrome X	5.8e-06	0.0027	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	5.76e-06	0.00268	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—CCL5—metabolic syndrome X	5.65e-06	0.00263	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—CCL5—metabolic syndrome X	5.53e-06	0.00257	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—metabolic syndrome X	5.41e-06	0.00252	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—metabolic syndrome X	5.41e-06	0.00252	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—MTNR1B—metabolic syndrome X	5.35e-06	0.00249	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—MTNR1B—metabolic syndrome X	5.23e-06	0.00244	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	5.11e-06	0.00238	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	5e-06	0.00233	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	4.78e-06	0.00222	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—AGT—metabolic syndrome X	4.73e-06	0.0022	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—AGT—metabolic syndrome X	4.62e-06	0.00215	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR2C—metabolic syndrome X	4.59e-06	0.00214	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	4.53e-06	0.00211	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR2C—metabolic syndrome X	4.49e-06	0.00209	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—GHRL—metabolic syndrome X	4.35e-06	0.00203	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—GHRL—metabolic syndrome X	4.25e-06	0.00198	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR2C—metabolic syndrome X	4.17e-06	0.00194	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CNR1—metabolic syndrome X	4.12e-06	0.00192	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR2C—metabolic syndrome X	4.08e-06	0.0019	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CNR1—metabolic syndrome X	4.03e-06	0.00188	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—GHRL—metabolic syndrome X	3.95e-06	0.00184	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	3.94e-06	0.00183	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—CCL2—metabolic syndrome X	3.89e-06	0.00181	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—GHRL—metabolic syndrome X	3.86e-06	0.0018	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	3.85e-06	0.00179	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—CCL2—metabolic syndrome X	3.81e-06	0.00177	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CNR1—metabolic syndrome X	3.74e-06	0.00174	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	3.73e-06	0.00174	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	3.69e-06	0.00172	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CNR1—metabolic syndrome X	3.66e-06	0.0017	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HDAC3—metabolic syndrome X	3.53e-06	0.00165	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—FMO3—metabolic syndrome X	3.52e-06	0.00164	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HDAC3—metabolic syndrome X	3.46e-06	0.00161	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	3.43e-06	0.0016	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—CCL5—metabolic syndrome X	3.19e-06	0.00149	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MTNR1B—metabolic syndrome X	3.16e-06	0.00147	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MLXIPL—metabolic syndrome X	3.14e-06	0.00146	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—EPHX2—metabolic syndrome X	3.14e-06	0.00146	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—CCL5—metabolic syndrome X	3.12e-06	0.00145	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MTNR1B—metabolic syndrome X	3.09e-06	0.00144	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TRIB3—metabolic syndrome X	3.08e-06	0.00143	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RBP4—metabolic syndrome X	3.08e-06	0.00143	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	3.06e-06	0.00142	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	3.04e-06	0.00142	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TRIB3—metabolic syndrome X	3.01e-06	0.0014	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RBP4—metabolic syndrome X	3.01e-06	0.0014	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—FMO3—metabolic syndrome X	2.98e-06	0.00139	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—G6PC2—metabolic syndrome X	2.95e-06	0.00137	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	2.95e-06	0.00137	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CCL5—metabolic syndrome X	2.9e-06	0.00135	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	2.89e-06	0.00134	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CCL5—metabolic syndrome X	2.84e-06	0.00132	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	2.83e-06	0.00132	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	2.83e-06	0.00132	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	2.74e-06	0.00128	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOC3—metabolic syndrome X	2.73e-06	0.00127	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AGT—metabolic syndrome X	2.67e-06	0.00124	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	2.67e-06	0.00124	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOC3—metabolic syndrome X	2.67e-06	0.00124	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MLXIPL—metabolic syndrome X	2.66e-06	0.00124	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—EPHX2—metabolic syndrome X	2.66e-06	0.00124	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AGT—metabolic syndrome X	2.61e-06	0.00122	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—FABP4—metabolic syndrome X	2.51e-06	0.00117	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	2.5e-06	0.00116	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2C—metabolic syndrome X	2.46e-06	0.00115	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AGT—metabolic syndrome X	2.43e-06	0.00113	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2C—metabolic syndrome X	2.41e-06	0.00112	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CYBA—metabolic syndrome X	2.38e-06	0.00111	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	2.38e-06	0.00111	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	2.38e-06	0.00111	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AGT—metabolic syndrome X	2.37e-06	0.0011	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GHRL—metabolic syndrome X	2.33e-06	0.00109	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CYBA—metabolic syndrome X	2.33e-06	0.00109	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	2.3e-06	0.00107	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GHRL—metabolic syndrome X	2.28e-06	0.00106	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CNR1—metabolic syndrome X	2.21e-06	0.00103	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CNR1—metabolic syndrome X	2.16e-06	0.00101	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—FABP4—metabolic syndrome X	2.13e-06	0.00099	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—G6PD—metabolic syndrome X	2.12e-06	0.000988	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	2.07e-06	0.000964	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GCKR—metabolic syndrome X	2.02e-06	0.000942	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LPA—metabolic syndrome X	2.02e-06	0.000942	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	2.02e-06	0.000939	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—CCL2—metabolic syndrome X	2e-06	0.00093	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	1.96e-06	0.000913	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.95e-06	0.00091	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—CCL2—metabolic syndrome X	1.95e-06	0.00091	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA5—metabolic syndrome X	1.94e-06	0.000903	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.9e-06	0.000885	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.87e-06	0.000869	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF2—metabolic syndrome X	1.81e-06	0.000841	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	1.8e-06	0.00084	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—G6PD—metabolic syndrome X	1.8e-06	0.000837	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.77e-06	0.000826	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF2—metabolic syndrome X	1.77e-06	0.000823	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	1.75e-06	0.000817	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOB—metabolic syndrome X	1.75e-06	0.000817	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOB—metabolic syndrome X	1.72e-06	0.000799	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPA—metabolic syndrome X	1.71e-06	0.000798	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GCKR—metabolic syndrome X	1.71e-06	0.000798	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL5—metabolic syndrome X	1.71e-06	0.000797	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.71e-06	0.000794	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL5—metabolic syndrome X	1.68e-06	0.00078	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LPL—metabolic syndrome X	1.67e-06	0.00078	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.67e-06	0.000777	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	1.66e-06	0.000773	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.65e-06	0.000768	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA5—metabolic syndrome X	1.64e-06	0.000765	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LPL—metabolic syndrome X	1.64e-06	0.000763	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	1.62e-06	0.000753	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GCK—metabolic syndrome X	1.61e-06	0.000749	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LIPC—metabolic syndrome X	1.61e-06	0.000749	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOC3—metabolic syndrome X	1.6e-06	0.000744	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.6e-06	0.000743	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.56e-06	0.000728	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CETP—metabolic syndrome X	1.55e-06	0.000722	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.55e-06	0.00072	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	1.53e-06	0.000711	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	1.49e-06	0.000692	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	1.44e-06	0.000671	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AGT—metabolic syndrome X	1.43e-06	0.000667	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOE—metabolic syndrome X	1.4e-06	0.000654	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—LEP—metabolic syndrome X	1.4e-06	0.000654	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	1.4e-06	0.000653	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GOT2—metabolic syndrome X	1.4e-06	0.000653	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AGT—metabolic syndrome X	1.4e-06	0.000652	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOA1—metabolic syndrome X	1.39e-06	0.000646	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—LEP—metabolic syndrome X	1.37e-06	0.000639	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOE—metabolic syndrome X	1.37e-06	0.000639	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	1.37e-06	0.000638	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.36e-06	0.000634	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LIPC—metabolic syndrome X	1.36e-06	0.000634	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GCK—metabolic syndrome X	1.36e-06	0.000634	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOA1—metabolic syndrome X	1.36e-06	0.000632	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOC3—metabolic syndrome X	1.35e-06	0.00063	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CETP—metabolic syndrome X	1.31e-06	0.000612	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	1.26e-06	0.000586	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IRS1—metabolic syndrome X	1.25e-06	0.000583	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.25e-06	0.000582	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.25e-06	0.000582	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.23e-06	0.00057	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IRS1—metabolic syndrome X	1.22e-06	0.00057	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	1.22e-06	0.000569	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.21e-06	0.000564	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.21e-06	0.000564	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INS—metabolic syndrome X	1.2e-06	0.000558	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	1.19e-06	0.000553	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GOT2—metabolic syndrome X	1.19e-06	0.000553	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CCL2—metabolic syndrome X	1.18e-06	0.000549	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INS—metabolic syndrome X	1.17e-06	0.000546	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-06	0.00054	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	1.15e-06	0.000537	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	1.13e-06	0.000528	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.1e-06	0.000513	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.08e-06	0.000502	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.07e-06	0.000499	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.06e-06	0.000493	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.06e-06	0.000493	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-06	0.00049	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	1.03e-06	0.000479	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.03e-06	0.000478	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.03e-06	0.000478	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.03e-06	0.000478	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1e-06	0.000465	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—LPL—metabolic syndrome X	9.81e-07	0.000457	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CD36—metabolic syndrome X	9.32e-07	0.000434	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	9.01e-07	0.00042	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	8.87e-07	0.000413	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	8.81e-07	0.00041	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOB—metabolic syndrome X	8.7e-07	0.000405	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	8.68e-07	0.000404	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARA—metabolic syndrome X	8.67e-07	0.000403	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	8.47e-07	0.000394	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AGT—metabolic syndrome X	8.39e-07	0.000391	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—LPL—metabolic syndrome X	8.31e-07	0.000387	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOE—metabolic syndrome X	8.22e-07	0.000383	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	8.18e-07	0.000381	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOA1—metabolic syndrome X	8.13e-07	0.000378	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	8e-07	0.000373	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CD36—metabolic syndrome X	7.9e-07	0.000368	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARA—metabolic syndrome X	7.34e-07	0.000342	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PPARG—metabolic syndrome X	7.16e-07	0.000334	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AGT—metabolic syndrome X	7.11e-07	0.000331	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—INS—metabolic syndrome X	7.03e-07	0.000327	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOE—metabolic syndrome X	6.97e-07	0.000324	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	6.95e-07	0.000324	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOA1—metabolic syndrome X	6.89e-07	0.000321	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	6.8e-07	0.000317	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ALB—metabolic syndrome X	6.44e-07	0.0003	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NOS3—metabolic syndrome X	6.16e-07	0.000287	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PPARG—metabolic syndrome X	6.07e-07	0.000283	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—INS—metabolic syndrome X	5.95e-07	0.000277	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	5.63e-07	0.000262	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ALB—metabolic syndrome X	5.46e-07	0.000254	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	5.24e-07	0.000244	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NOS3—metabolic syndrome X	5.22e-07	0.000243	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	5.13e-07	0.000239	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	4.83e-07	0.000225	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	4.77e-07	0.000222	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	4.73e-07	0.00022	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.83e-07	0.000132	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.4e-07	0.000112	CbGpPWpGaD
